These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32496998)

  • 1. Treatment Modalities of Psoriasis: A Focus on Requisite for Topical Nanocarrier.
    Ramanunny AK; Wadhwa S; Thakur D; Singh SK; Kumar R
    Endocr Metab Immune Disord Drug Targets; 2021; 21(3):418-433. PubMed ID: 32496998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psoriasis clinical implications and treatment: a review.
    Raut AS; Prabhu RH; Patravale VB
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):183-216. PubMed ID: 23614646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
    Bessar H; Venditti I; Benassi L; Vaschieri C; Azzoni P; Pellacani G; Magnoni C; Botti E; Casagrande V; Federici M; Costanzo A; Fontana L; Testa G; Mostafa FF; Ibrahim SA; Russo MV; Fratoddi I
    Colloids Surf B Biointerfaces; 2016 May; 141():141-147. PubMed ID: 26852097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging landscape in psoriasis management: From topical application to targeting biomolecules.
    Rapalli VK; Singhvi G; Dubey SK; Gupta G; Chellappan DK; Dua K
    Biomed Pharmacother; 2018 Oct; 106():707-713. PubMed ID: 29990862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, and
    Walunj M; Doppalapudi S; Bulbake U; Khan W
    J Liposome Res; 2020 Mar; 30(1):68-79. PubMed ID: 30897993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers.
    Pinto MF; Moura CC; Nunes C; Segundo MA; Costa Lima SA; Reis S
    Int J Pharm; 2014 Dec; 477(1-2):519-26. PubMed ID: 25445970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis.
    An P; Zhao Q; Hao S; Wang X; Tian J; Ma Z
    Int J Nanomedicine; 2024; 19():7631-7671. PubMed ID: 39099792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Approaches on Novel Topical Delivery Systems for Atopic Dermatitis Treatment.
    Kahraman E; Aydilek N; Güngör S
    Recent Pat Drug Deliv Formul; 2020; 14(3):191-200. PubMed ID: 32819264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of psoriasis with topical agents: Recommendations from a Tuscany Consensus.
    Chiricozzi A; Pimpinelli N; Ricceri F; Bagnoni G; Bartoli L; Bellini M; Brandini L; Caproni M; Castelli A; Fimiani M; Marsili F; Mazzatenta C; Niccoli MC; Panduri S; Pellegrino M; Sirna R; Volpi W; Romanelli M; Prignano F
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28940579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How can nanoparticle-based technologies revolutionize the topical therapy in psoriasis?
    Sindrilaru A; Filip A; Scharffetter-Kochanek K; Crisan D
    Exp Dermatol; 2020 Nov; 29(11):1097-1103. PubMed ID: 32657487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis.
    Fereig SA; El-Zaafarany GM; Arafa MG; Abdel-Mottaleb MMA
    Drug Deliv; 2020 Dec; 27(1):662-680. PubMed ID: 32393082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
    Börjesson C; Guinard E; Tauber M; Konstantinou MP; Livideanu CB; Mazereeuw-Hautier J; Meyer N; Paul C
    Dermatol Ther; 2019 Jan; 32(1):e12780. PubMed ID: 30387924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanodelivery Systems for Topical Management of Skin Disorders.
    Cui M; Wiraja C; Chew SWT; Xu C
    Mol Pharm; 2021 Feb; 18(2):491-505. PubMed ID: 32470311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
    Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
    Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
    Gungor S; Rezigue M
    Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advancement in Topical Nanocarriers for the Treatment of Psoriasis.
    Biswasroy P; Pradhan D; Kar B; Ghosh G; Rath G
    AAPS PharmSciTech; 2021 May; 22(5):164. PubMed ID: 34041632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
    Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
    Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
    Feng H; Wu R; Zhang S; Kong Y; Liu Z; Wu H; Wang H; Su Y; Zhao M; Lu Q
    J Dermatol; 2020 Feb; 47(2):147-154. PubMed ID: 31773789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model.
    Sathe P; Saka R; Kommineni N; Raza K; Khan W
    Drug Dev Ind Pharm; 2019 May; 45(5):826-838. PubMed ID: 30764674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.